America Latina Times
SEE OTHER BRANDS

The most trusted news from Latin America

America Latina Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.

Press releases published on May 7, 2025

PDS Biotech Announces Conference Call and Webcast for First Quarter 2025 Financial Results

PDS Biotech Announces Conference Call and Webcast for First Quarter 2025 Financial Results

PRINCETON, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …

Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments

Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments

Highly differentiated immunotherapy for celiac disease (VTP-1000) in the clinic, with Phase 1 single ascending dose readout from AVALON expected in the third quarter of 2025; Initiation of VTP-1000 multiple ascending dose expected in the second half of …

BridgeBio to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 2025

BridgeBio to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 2025

PALO ALTO, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will …

Amerigo Announces Q1-2025 Results & Quarterly Dividend

Amerigo Announces Q1-2025 Results & Quarterly Dividend

Q1-2025 Net Income of $3.3 million Robust EBITDA1 of $15.2 million and Free Cash Flow to Equity1 of $4.8 million 15th Quarterly Dividend of Cdn$.03 Declared $4.6 million Returned through Dividends and Share Buybacks in Q1-2025 VANCOUVER, British Columbia, …

InflaRx Reports First Quarter 2025 Financial Results and Provides Business Update

InflaRx Reports First Quarter 2025 Financial Results and Provides Business Update

Announces successful completion of sub-chronic and chronic toxicology studies for INF904, supporting long-term dosing in future clinical trials Multiple near-term catalysts anticipated with the potential to substantially de-risk the Company's pipeline …

Y-mAbs Announces Update to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for Neuroblastoma to Include Naxitamab-gqgk (DANYELZA®)

Y-mAbs Announces Update to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for Neuroblastoma to Include Naxitamab-gqgk (DANYELZA®)

PRINCETON, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody- …

Spectral Medical Announces Non-Dilutive Financing of Up to $10 Million with Vantive

Spectral Medical Announces Non-Dilutive Financing of Up to $10 Million with Vantive

•  Non-Dilutive Financing •  Up to US$10 Million Promissory Note Provided by Vantive •  If Fully Drawn, Promissory Note is Expected to Fully Fund Spectral to PMX Commercialization •  Company to host Corporate Update Call on May 15, 2025 TORONTO, May 07, …

Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies

Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies

MILAN and NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, today announced a collaboration with Anemocyte, a leading Biotech Manufacturing Organization (BMO) …

Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results

Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results

Generated $166.8 million in 1Q 2025 revenues, including $149.9 million in U.S. net product sales SYFOVRE® (pegcetacoplan injection) injection demand grew 4% quarter-over-quarter, with U.S. net product revenue of $130.2 million Increase in demand offset by …

Lirum Therapeutics Announces New LX-101 Data in Thyroid Eye Disease Selected for Presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting

Lirum Therapeutics Announces New LX-101 Data in Thyroid Eye Disease Selected for Presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting

New York, NY, May 07, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today that new results with LX-101 in Thyroid Eye Disease …

Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting

Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting

Codexis to showcase data that demonstrate the scalability and reproducibility of its enzymatic siRNA manufacturing processes Three CDMO presentations to feature data on performance of Codexis double-stranded RNA ligases Management will host a conference …

Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update

Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update

-- First quarter 2025 net product revenue from global sales of IMCIVREE® (setmelanotide) of $37.7 million -- -- Setmelanotide pivotal Phase 3 TRANSCEND trial met primary endpoint with -19.8% placebo-adjusted BMI reduction in patients (N=120) with acquired …

Robex Lodges Replacement Prospectus for IPO

Robex Lodges Replacement Prospectus for IPO

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE U.S. QUÉBEC CITY, May 07, 2025 (GLOBE NEWSWIRE) -- West African gold producer and developer Robex Resources Inc (“Robex” or the “Company”) (TSX-V: RBX) announces that, in reference to …

XRP News Today: CME to Launch XRP Futures on May 19 — StratoVM Surges 2,939% as Analysts Eye $10 XRP Target This Summer

XRP News Today: CME to Launch XRP Futures on May 19 — StratoVM Surges 2,939% as Analysts Eye $10 XRP Target This Summer

ROAD TOWN, British Virgin Islands, May 07, 2025 (GLOBE NEWSWIRE) -- XRP News Today – Ripple is making headlines once again as CME Group gears up to launch XRP futures on May 19, signaling a potential surge in institutional interest. Combined with improving …

Newcore Gold Drilling Intersects 2.25 g/t Gold over 56.0 Metres from 96 Metres and 1.16 g/t Gold over 72.0 Metres from 104 Metres at the Enchi Gold Project, Ghana

Newcore Gold Drilling Intersects 2.25 g/t Gold over 56.0 Metres from 96 Metres and 1.16 g/t Gold over 72.0 Metres from 104 Metres at the Enchi Gold Project, Ghana

VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- Newcore Gold Ltd. ("Newcore" or the "Company") (TSX-V: NCAU, OTCQX: NCAUF) is pleased to announce additional drill results from the 35,000-metre drill program underway at the Company’s 100% …

The Future of Polyverse: Exciting Growth and Upcoming Milestones

The Future of Polyverse: Exciting Growth and Upcoming Milestones

Polyverse is positioning itself to be a major player in the rapidly growing blockchain gaming space. With its combination of browser-based gameplay, Play-to-Earn mechanics, and innovative token systems, Polyverse is set to redefine blockchain gaming. After …

First Atlantic Nickel Starts Phase 2 Drilling to Expand New Nickel Discovery at RPM Zone in District-Scale Atlantic Nickel Project

First Atlantic Nickel Starts Phase 2 Drilling to Expand New Nickel Discovery at RPM Zone in District-Scale Atlantic Nickel Project

VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) (“First Atlantic” or the “Company”) is excited to announce the commencement of Phase 2 drilling at the RPM Zone on its 100%- …

Oculis to Present at Upcoming May Investor Conferences

Oculis to Present at Upcoming May Investor Conferences

ZUG, Switzerland, May 07, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service